SACRA Therapeutics
Investor
SACRA Therapeutics
Description
SACRA Therapeutics pioneers novel therapeutic strategies based on selective targeting of RNA modifying proteins for treating incurable solid and hematological cancers.
SACRA Therapeutics
Address
c/o Red Glead Discovery AB, Medicon Village, 22381 Lund
Lund, Sweden
Lund, Sweden
Contact
info@sacratx.com
Description
SACRA Therapeutics pioneers novel therapeutic strategies based on selective targeting of RNA modifying proteins for treating incurable solid and hematological cancers.
Matchmaking
Connect with SACRA Therapeutics
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways